News, reviews and podcasts from annual scientific meetings and symposiums around the world.
In patients with metastatic hormone receptor (HR)-positive/HER2-negative breast cancer unselected by PD-L1 status, adding the…
A drug that targets a protein involved in regulating the immune response might be promising…
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center, USA, reported promising preliminary findings based on…
Almost one out of five breast cancer survivors may experience weight gain of more than…
While CAR T cell therapy has revolutionised treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many…
A new study led by investigators from Mass General Cancer Center, USA, reveals the effectiveness…
An immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more…
Telemedicine visits for cancer care may not only be more convenient and easier to schedule…
Initial data from the first phase 1 trial of the bispecific antibody FS222 demonstrate that…
Estelamari Rodriguez, M.D., M.P.H., is the recipient of the Patient Educator of the Year award…